S-EPMC4649298 - Combination of intravenously delivered cavatak (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and tumor rechallenge - OmicsDI

Unknown

Dataset Information

Combination of intravenously delivered cavatak (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and tumor rechallenge

ABSTRACT:

SUBMITTER: Yuan M

PROVIDER: S-EPMC4649298 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature